A new JDRF International-funded study of a drug called verapamil is offering exciting new potential for a path to keeping beta cells healthier for longer in people with type 1 […]
The causes of type 1 diabetes (T1D) are complex and not fully understood. What is known is that there is a genetic component to developing T1D – but who is […]
A significant part of JDRF Canada’s research strategy is funding the most promising cure-based research for type 1 diabetes (T1D). T1D is an autoimmune disease where the body destroys the […]
Every two years, more than 160 children living with type 1 diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. […]
A newly re-tooled third-party fundraising program is now available across Canada: JDRF Your Way. Support. Participate. Fundraise… Your Way JDRF’s foundations lie in grassroots efforts and fundraising, and our accomplishments as […]
As we got through the height of the pandemic in 2021 and moved into 2022, we believed that it would be a year of hope. And thanks to the support […]
It’s the holiday season, and for most people that means indulging in seasonal treats and meals. It’s no different for people living with type 1 diabetes (T1D). One of the […]
In November, to celebrate World Diabetes Day, the BETTER (BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes) project announced that it is now the first registry of people […]
JDRF’s Kids For a Cure advocacy event was held from November 13- 15 in Ottawa and what an impact our youth delegates made – engaging with more than 55 Members […]
A diagnosis of type 1 diabetes (T1D) changes the trajectory of an entire family. This was no different for the Turner Family when Alex was diagnosed at 14-years-old. The Turners […]
December 2021 marked the launch of the JDRF Centre of Excellence at the University of British Columbia (UBC). One year later, a team of over 40 researchers convened in person […]
This is the first therapeutic on the market that may help delay the onset of clinicaltype 1 diabetes November 17, 2022 Today, the U.S. Food and Drug Administration (FDA) weighed […]
